Venus Medtech (Hangzhou) Inc.
HKEX:2500.HK
3.7 (HKD) • At close August 29, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
| Revenue
| 470.833 | 491.373 | 406.461 | 415.862 | 276.047 | 233.272 | 115.348 | 18.164 |
| Cost of Revenue
| 103.087 | 102.168 | 92.463 | 91.518 | 48.767 | 38.607 | 16.368 | 3.077 |
| Gross Profit
| 367.746 | 389.205 | 313.998 | 324.344 | 227.28 | 194.665 | 98.98 | 15.087 |
| Gross Profit Ratio
| 0.781 | 0.792 | 0.773 | 0.78 | 0.823 | 0.834 | 0.858 | 0.831 |
| Reseach & Development Expenses
| 341.185 | 524.915 | 527.451 | 258.336 | 167.251 | 200.531 | 104.774 | 117.36 |
| General & Administrative Expenses
| 146.026 | 153.786 | 192.178 | 128.585 | 104.064 | 197.608 | 32.643 | 11.236 |
| Selling & Marketing Expenses
| 245.066 | 300.477 | 260.382 | 216.067 | 134.572 | 124.567 | 66.865 | 35.922 |
| SG&A
| 391.092 | 454.263 | 452.56 | 344.652 | 238.636 | 322.175 | 99.508 | 47.158 |
| Other Expenses
| -17.934 | -18.894 | -31.128 | -6.687 | -29.749 | -9.189 | -11.314 | -0.24 |
| Operating Expenses
| 714.343 | 960.284 | 948.883 | 596.301 | 376.138 | 513.517 | 393.466 | 168.969 |
| Operating Income
| -346.597 | -589.973 | -1,089.749 | -621.527 | -237.245 | -370.357 | -294.722 | -155.608 |
| Operating Income Ratio
| -0.736 | -1.201 | -2.681 | -1.495 | -0.859 | -1.588 | -2.555 | -8.567 |
| Total Other Income Expenses Net
| -394.116 | -145.367 | -521.459 | -105.598 | -7.236 | -11.186 | -5.134 | -1.84 |
| Income Before Tax
| -740.713 | -735.34 | -1,156.344 | -377.555 | -185.843 | -381.543 | -299.62 | -157.448 |
| Income Before Tax Ratio
| -1.573 | -1.497 | -2.845 | -0.908 | -0.673 | -1.636 | -2.598 | -8.668 |
| Income Tax Expense
| -23.34 | -6.284 | -34.302 | -6.161 | -2.975 | -0.778 | 0.898 | 0.5 |
| Net Income
| -714.307 | -703.754 | -1,122.042 | -371.394 | -182.868 | -380.765 | -300.421 | -156.532 |
| Net Income Ratio
| -1.517 | -1.432 | -2.761 | -0.893 | -0.662 | -1.632 | -2.604 | -8.618 |
| EPS
| -1.77 | -1.61 | -2.56 | -0.85 | -0.45 | -1.22 | -0.77 | -0.4 |
| EPS Diluted
| -1.77 | -1.61 | -2.56 | -0.85 | -0.45 | -1.22 | -0.77 | -0.4 |
| EBITDA
| -612.957 | -547.837 | -999.369 | -324.029 | -152.832 | -343.623 | -286.353 | -149.625 |
| EBITDA Ratio
| -1.302 | -1.115 | -2.459 | -0.779 | -0.554 | -1.473 | -2.483 | -8.237 |